Le Lézard
Classified in: Health
Subjects: NPT, BFA, PSF

New Short Film Brings Opioid Users Face to Face With Those Who've Lost Loved Ones to Overdose


ITASCA, Ill., Dec. 5, 2017 /PRNewswire/ -- One in four Americans has been directly impacted by the opioid crisis, but 40 percent still do not consider it to be a health and safety threat to their family, according to recent National Safety Council poll results. In an attempt to end this persistent indifference, the Council today released a powerful short film that brings opioid users face to face with those who have been personally impacted by the worst drug crisis in recorded U.S. history. The video, titled Facing an Everyday Killer, is part of the Council's Stop Everyday Killers campaign ? a public awareness initiative to help educate about the risks of taking opioids and encourage people to explore other pain treatment options.  

Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8207151-national-safety-council-stop-everyday-killers-opioids/

Facing an Everyday Killer illustrates the potential for a well-intentioned opioid user to become a statistic ? a trend that is much too common. Far too many opioid misuse disorders begin with valid prescriptions following an injury or surgery.

"The most important thing to know about this crisis is not the numbers and statistics, but the faces," said Deborah A.P. Hersman, president and CEO of the National Safety Council. "The data speak to our head but the individual stories speak to our hearts. The Facing an Everyday Killer video not only puts an image on the scope of the problem, but also encourages actions that will help us eliminate these preventable deaths."

Facing an Everyday Killer includes sweeping footage of the Council's Prescribed to Death Memorial that launched in Chicago on November 9 and drew hundreds of visitors who came to remember, learn and act. The Memorial includes a wall with 22,000 engraved pills, each carved with the image of someone who fatally overdosed last year. It will travel across the country, with a stop planned in Pittsburgh in late January.

The short film can be downloaded via YouTube, accessed at stopeverydaykillers.org and shared on social media using the hashtag  #StopEverydayKillers.

About the National Safety Council
The National Safety Council (nsc.org) is a nonprofit organization whose mission is to eliminate preventable deaths at work, in homes and communities, and on the road through leadership, research, education and advocacy. Founded in 1913 and chartered by Congress, NSC advances this mission by partnering with businesses, government agencies, elected officials and the public in areas where we can make the most impact.

Connect with NSC:

Facebook
Twitter
LinkedIn
YouTube

Contact: Maureen Vogel
Senior Manager, Public Relations
(630) 775-2307

 

 

 

Infographic

 

Opioids: Warn Me!

 

SOURCE National Safety Council


These press releases may also interest you

at 23:38
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

at 23:33
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: